Qatari entrepreneurs are seriously interested in investing in Ukraine, including one of the largest agricultural companies in the country, Hassad Food, which is looking for partners for the production of animal feed and eggs, the Ukrainian Chamber of Commerce and Industry (UCCI) reported on its website.
According to its data, representatives of the largest companies of Qatar arrived in Ukraine as part of a delegation to participate in the second meeting of the joint commission on economic, trade and technical cooperation between the governments of Ukraine and Qatar.
It is clarified that Ukrainian grain traders and animal feed manufacturers at a meeting with Hassad Food Executive Director Mubarak Al-Suhooti discussed prospects for cooperation.
“The international campaign Hassad Food Company invests in production in other countries. In Ukraine, in particular, they are looking for partners for the production of animal feed and eggs, so Ukrainian entrepreneurs presented their capabilities,” the UCCI said.
During the talks between President of the Ukrainian Chamber of Commerce and Industry Hennadiy Chizhikov and First Vice Chairman of the Qatar Chamber of Commerce and Industry H.E Ali bin Ahmed Al Kuwari, the latter said that Qatari entrepreneurs are considering Ukraine for investment.
Chizhikov stressed that the composition of the representatives of the Qatari delegation testifies to the serious investment interest of this country in Ukraine. He urged Ukrainian business to take advantage of trade opportunities.
Ukrainian legislation should enable pharmaceutical manufacturers to buy a license for the production of a COVID-19 vaccine, which can be developed by foreign companies, Head of the supervisory board of JSC Farmak (Kyiv) Filya Zhebrovska has said.
“Ukrainian legislation should provide an opportunity so that we can buy or use a license, possibly pay royalties, so that we have the opportunity to produce this vaccine,” the company’s press service reported, quoting her as saying.
Zhebrovska said that the possibility of buying a license to produce a COVID-19 vaccine at Ukrainian production facilities will reduce the price of this vaccine by 15-20% compared with the purchase of the finished product.
As reported, Farmak does not rule out the possibility of joining a consortium, which the European Investment Bank (EIB), together with WHO, created to develop the COVID-19 vaccine. The EIB allocated EUR 7.6 billion to this consortium.
In the middle of May, Farmak, as part of international research, began the third phase of clinical trials of the Amizon drug (Enisamium) in fighting COVID-19 in Ukraine.
Farmak is the leader in the pharmaceutical market with a share of 5.9% in monetary terms. The company annually reinvests of approximately 95% of the profits in its development.
Farmak is a member of the Manufacturers of Medications of Ukraine association.
According to the public register, the ultimate beneficial owner of PJSC Farmak is Zhebrovska, who holds 80% of shares in the company.
Ukrainian vehicle manufacturers in 2019 tentatively produced 7,265 vehicles, which is 10% more than in 2018, the Ukrautoprom association has reported.
At the same time, the output of passenger cars last year increased 10.5%, to 6254 cars and all of them were manufactured at the Eurocar factory (in 2018 also, with the exception of one car made at ZAZ), buses production grew by 5%, to 875 units, commercial vehicles and trucks – by 3%, to 136 units (excluding AvtoKrAZ, which has ceased to disclose information about production since August 2016).
According to the association’s statistics, the lion’s share (126 units) in the production of commercial vehicles belongs to JSC Cherkasy Bus, which increased their production by 2.6 times, while ZAZ reduced it by 82.5%, to 15 units.
Cherkasy Bus is also a leader in the production of buses: over the past year, 441 buses were produced (the same as in 2018). Chernihiv Automobile Plant of Etalon Corporation is second. It increased production by 7%, to 202 units, and Chasiv Yar Buses is third (94 buses compared with 107 in 2018).
Another 68 buses were produced by Bogdan Corporation (a year earlier there were 50 units made), ZAZ produced 70 units compared with 45 units in 2018.
The association said that the growth rate of vehicle production accelerated by the end of the year, which was thanks to the results of December, when vehicle production doubled compared with December 2018, to 557 units thanks to an increase of 2.2 times in the assembly of Skoda cars at the Eurocar, to 432 cars.
Only Cherkasy Bus reported on the production of commercial vehicles, where 20 vehicles were manufactured in December.
Last month, bus production increased by 38%, to 105 units, including 60 units made by Cherkasy Bus (compared with 40 a year earlier), the Chernihiv Automobile Plant made 28 buses (15), Chasiv Yar Buses manufactured 11 buses (3), and 6 buses were produced by ZAZ (11).
Six Ukrainian automobile plants produced 675 vehicles in April 2018, which is 13% less than in March 2018, the Ukrautoprom association has said. According to preliminary data, production of vehicles compared with April 2017 grew by 8.7%. Eurocar, the Skoda car manufacturer, cut production in April by 10% compared with March 2018, to 615 cars. Production grew by almost 8% year-over-year. Eurocar was the only producer of passenger cars in Ukraine in April.
Bus production fell by 13% compared with March 2018, to 54, including three buses made by ZAZ, one each by Bogdan Corporation and Chernihiv Automobile Plant of Etalon Corporation. Chasiv Yar Plant made 14 buses, and Cherkasy Bus – 35.
Only six commercial vehicles were made – one at ZAZ and five at Cherkasy Bus, while in March 2018 a total of 62 vehicles were made and in February – 80.
AutoKrAZ did not provide information on its production figures.
The association said that in January-April 2018, vehicle production grew by 32.7% year-over-year, to 2,739. Passenger car output grew by 31%, to 2,383 (all made at Eurocar), bus production – by 16%, to 255, and commercial vehicle output (without figures of AutoKrAZ) fell by 34%, to 101.